New device may prevent muscle loss in ventilator patients
NCT ID NCT05883163
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called STIMIT Activator 1 in 40 adults on ventilators for breathing support. The device aims to keep the diaphragm (the main breathing muscle) from weakening during ventilation. Participants are randomly assigned to receive the device or standard care, and doctors measure diaphragm thickness daily with ultrasound. The goal is to see if the device is safe and helps preserve muscle strength, potentially speeding recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAPHRAGM ISSUES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
St Michael's Hospital Unity Health Toronto
RECRUITINGToronto, Canada
-
University of Virginia Medical Center
RECRUITINGCharlottesville, Virginia, 22908, United States
-
Yale New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.